UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer

Annals of oncology, 2015-01, Vol.26 (1), p.141-148

2015

Volltextzugriff (PDF)

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours

British journal of cancer, 2012-07, Vol.107 (3), p.429-434

2012

Volltextzugriff (PDF)

Influence of Oral Anaerobic Bacteria on Hematopoietic Stem Cell Transplantation Patients: Oral Mucositis and General Condition

Transplantation proceedings, 2017-11, Vol.49 (9), p.2176-2182

2017

Volltextzugriff (PDF)

Effect of overlapping laser beams and density scale length in laser-plasma instability experiments on OMEGA EP

Physics of plasmas, 2023-04, Vol.30 (4)

2023

Volltextzugriff (PDF)

Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma

Annals of oncology, 2016-04, Vol.27 (4), p.673-679

2016

Volltextzugriff (PDF)

Examination of factors affecting the intraoral perception of object size: a preliminary study

Journal of oral rehabilitation, 2017-04, Vol.44 (4), p.237-243

2017

Volltextzugriff (PDF)

The nationwide cancer genome screening project in Japan, SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced esophageal cancer

Annals of oncology, 2018-10, Vol.29, p.viii211-viii211

2018

Volltextzugriff (PDF)

Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as the second-line treatment in patients with advanced gastric cancer

Annals of oncology, 2019-07, Vol.30, p.iv122-iv122

2019

Volltextzugriff (PDF)

Avelumab (anti–PD-L1) in Japanese patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC): Updated results from the phase Ib JAVELIN solid tumour JPN trial

Annals of oncology, 2018-10, Vol.29, p.viii221-viii222

2018

Volltextzugriff (PDF)

A phase III study of TAS-118 plus oxaliplatin versus S-1 plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer (SOLAR study)

Annals of oncology, 2019-07, Vol.30, p.iv153-iv153

2019

Volltextzugriff (PDF)

Randomized phase II study of FOLFIRI plus ramucirumab (Rmab) versus FOLFOXIRI plus Rmab as first-line treatment for patients with metastatic colorectal cancer (mCRC): WJOG9216G

Annals of oncology, 2018-10, Vol.29, p.viii201-viii201

2018

Volltextzugriff (PDF)

Evaluation of Sediment Transport Capacity Equations Using Basin Scale Process-Based Sediment Dynamic Modelling Approach

Water resources management, 2015-03, Vol.29 (4), p.1097-1116

2015

Volltextzugriff (PDF)

Process-based distributed modeling approach for analysis of sediment dynamics in a river basin

Hydrology and earth system sciences, 2011-01, Vol.15 (4), p.1307-1321

2011

Volltextzugriff (PDF)

Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer

British journal of cancer, 2014-01, Vol.110 (2), p.271-277

2014

Volltextzugriff (PDF)

A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)

ESMO open, 2022-12, Vol.7 (6), p.100592, Article 100592

2022

Volltextzugriff (PDF)

2301 Phase 2 study of Nivolumab (Anti-PD-1; ONO-4538) in Patients with Esophageal Cancer: Preliminary Report

European journal of cancer (1990), 2015-09, Vol.51, p.S432-S432

2015

Volltextzugriff (PDF)

Effect of Temperature on Antisolvent Crystallization and Transformation Behaviors of Thiazole-Derivative Polymorphs

Crystal growth & design, 2006-05, Vol.6 (5), p.1214-1218

2006

Volltextzugriff (PDF)

Evaluation of dual-bed pressure swing adsorption for CO2 recovery from boiler exhaust gas

Separation and purification technology, 2001-09, Vol.24 (3), p.519-528

2001

Volltextzugriff (PDF)

Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer

Diseases of the esophagus, 2008-05, Vol.21 (3), p.195-200

2008

Volltextzugriff (PDF)

6107 POSTER Improved Overall Survival in the Patients With Metastatic Colorectal Cancer Associated With Ant-VEGF Antibody Drug and Anti-EGFR Antibody Drug Administration

European journal of cancer (1990), 2011, Vol.47, p.S424-S424

2011

Volltextzugriff (PDF)

497TiP Randomized phase II trial of trifluridine/tipiracil plus ramucirumab versus trifluridine/tipiracil for pre-treated patients with advanced gastric or gastroesophageal junction adenocarcinoma (RETRIEVE study, WJOG15822G)

Annals of oncology, 2024-06, Vol.35, p.S198-S198

2024

Volltextzugriff (PDF)

1513MO A phase II study of nivolumab plus low dose ipilimumab as first -line therapy in patients with advanced gastric or esophago-gastric junction MSI-H tumor: First results of the NO LIMIT study (WJOG13320G/CA209-7W7)

Annals of oncology, 2023-10, Vol.34, p.S852-S853

2023

Volltextzugriff (PDF)

522P Impact of age and single heterozygous UGT1A1 on the safety and efficacy of first-line FOLFIRI or FOLFOXIRI in combination with ramucirumab (RAM) for metastatic colorectal cancer (mCRC): Subgroup analyses of WJOG9216G (RECAST)

Annals of oncology, 2024-09, Vol.35, p.S440-S440

2024

Volltextzugriff (PDF)

518MO Update analysis of the randomized phase II study comparing FOLFIRI plus ramucirumab (RAM) versus FOLFOXIRI plus RAM as first-line treatment for patients with metastatic colorectal cancer: WJOG9216G (RECAST)

Annals of oncology, 2024-09, Vol.35, p.S437-S437

2024

Volltextzugriff (PDF)

149P A prospective observational study of MSI screening in unresectable chemotherapy-naïve advanced gastric cancer/gastroesophageal junction cancer: WJOG13320GPS

Annals of oncology, 2023-11, Vol.34, p.S1532-S1533

2023

Volltextzugriff (PDF)

1 – 25 von 3.469

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.122)
Mit Volltextzugriff
(2.771)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(19)
... seit 30 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours

Influence of Oral Anaerobic Bacteria on Hematopoietic Stem Cell Transplantation Patients: Oral Mucositis and General Condition

Effect of overlapping laser beams and density scale length in laser-plasma instability experiments on OMEGA EP

Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma

Examination of factors affecting the intraoral perception of object size: a preliminary study

The nationwide cancer genome screening project in Japan, SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced esophageal cancer

Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as the second-line treatment in patients with advanced gastric cancer

Avelumab (anti–PD-L1) in Japanese patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC): Updated results from the phase Ib JAVELIN solid tumour JPN trial

A phase III study of TAS-118 plus oxaliplatin versus S-1 plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer (SOLAR study)

Randomized phase II study of FOLFIRI plus ramucirumab (Rmab) versus FOLFOXIRI plus Rmab as first-line treatment for patients with metastatic colorectal cancer (mCRC): WJOG9216G

Evaluation of Sediment Transport Capacity Equations Using Basin Scale Process-Based Sediment Dynamic Modelling Approach

Process-based distributed modeling approach for analysis of sediment dynamics in a river basin

Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer

A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)

2301 Phase 2 study of Nivolumab (Anti-PD-1; ONO-4538) in Patients with Esophageal Cancer: Preliminary Report

Effect of Temperature on Antisolvent Crystallization and Transformation Behaviors of Thiazole-Derivative Polymorphs

Evaluation of dual-bed pressure swing adsorption for CO2 recovery from boiler exhaust gas

Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer

6107 POSTER Improved Overall Survival in the Patients With Metastatic Colorectal Cancer Associated With Ant-VEGF Antibody Drug and Anti-EGFR Antibody Drug Administration

497TiP Randomized phase II trial of trifluridine/tipiracil plus ramucirumab versus trifluridine/tipiracil for pre-treated patients with advanced gastric or gastroesophageal junction adenocarcinoma (RETRIEVE study, WJOG15822G)

1513MO A phase II study of nivolumab plus low dose ipilimumab as first -line therapy in patients with advanced gastric or esophago-gastric junction MSI-H tumor: First results of the NO LIMIT study (WJOG13320G/CA209-7W7)

522P Impact of age and single heterozygous UGT1A1 on the safety and efficacy of first-line FOLFIRI or FOLFOXIRI in combination with ramucirumab (RAM) for metastatic colorectal cancer (mCRC): Subgroup analyses of WJOG9216G (RECAST)

518MO Update analysis of the randomized phase II study comparing FOLFIRI plus ramucirumab (RAM) versus FOLFOXIRI plus RAM as first-line treatment for patients with metastatic colorectal cancer: WJOG9216G (RECAST)

149P A prospective observational study of MSI screening in unresectable chemotherapy-naïve advanced gastric cancer/gastroesophageal junction cancer: WJOG13320GPS

Suchergebnisse filtern